Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.860
+0.010 (0.54%)
At close: Jul 22, 2026, 4:00 PM EDT
1.824
-0.036 (-1.94%)
After-hours: Jul 22, 2026, 7:34 PM EDT
Allogene Therapeutics Market Cap
Allogene Therapeutics has a market cap or net worth of $641.99 million as of July 22, 2026. Its market cap has increased by 122.35% in one year.
Market Cap
641.99M
Enterprise Value
456.15M
1-Year Change
122.35%
Ranking
Category
Stock Price
$1.86
ChartMarket Cap Chart
Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $641.99M, a decrease of -77.71%. That is a compound annual growth rate of -17.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 641.99M | 108.52% |
| Dec 31, 2025 | 307.88M | -31.06% |
| Dec 31, 2024 | 446.60M | -17.32% |
| Dec 29, 2023 | 540.17M | -40.45% |
| Dec 30, 2022 | 907.08M | -57.34% |
| Dec 31, 2021 | 2.13B | -39.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gyre Therapeutics | 674.51M |
| Faeth Therapeutics | 666.90M |
| SpyGlass Pharma | 660.98M |
| CorMedix | 660.56M |
| Achieve Life Sciences | 643.67M |
| MiMedx Group | 640.47M |
| Tectonic Therapeutic | 615.14M |
| Nuvectis Pharma | 603.40M |